FDA Inspection 983868 — Stanford Health Care Transfusion Service
The FDA completed an inspection of Stanford Health Care Transfusion Service on July 26, 2016 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Palo Alto, CA (United States)